Drugs in the Pipeline
The bile acid sequestrant was designed to be maintained in the stomach over an extended period of time where it was expected to intercept bile before it reached the esophagus.
A recently published report describes the case of a 61-year-old male patient who experienced antacid-induced hypercalcemia and highlights the importance of performing thorough medication reconciliation.
Talicia (omeprazole magnesium, amoxicillin and rifabutin delayed-release capsules) has been made available for the treatment of Helicobacter pylori (H. pylori) infection in adults, according to RedHill Biopharma.
Dr. Reddy’s Laboratories announced the launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, the generic equivalent to Vimovo® (Horizon Pharma).
Several treatments were attempted but failed to manage the patient’s conditions, including proton pump inhibitors, topical steroids, a restricted diet, and infliximab (3 doses) for arthritis.
Patients on continuous proton pump inhibitor (PPI) therapy may be at increased risk of developing acute gastroenteritis during the winter season, when the circulation of enteric viruses is highest, according to findings from a recent matched cohort study. While previous research has reported an association between continuous PPI use and an increased risk of acute…
The FDA has approved Talicia (omeprazole magnesium, amoxicillin and rifabutin delayed-release capsules; RedHill Biopharma) for the treatment of Helicobacter pylori (H. pylori) infection in adults.
To shed light on this complex subject, MPR interviewed Joshua D Brown, PharmD, PhD, Assistant Professor, Pharmaceutical Outcomes & Policy.
A recent review published in the journal Pharmacotherapy summarizes recommendations for the treatment of Helicobacter pylori infection in special patient populations.
Prescription drug use appears to be similar in the US and Canada, according to a new data brief from the Centers for Disease Control and Prevention (CDC).